[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer

Eur J Nucl Med Mol Imaging. 2015 May;42(6):987-8. doi: 10.1007/s00259-014-2978-1. Epub 2015 Jan 9.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antigens, Surface / metabolism*
  • Glutamate Carboxypeptidase II / metabolism*
  • Humans
  • Male
  • Multimodal Imaging
  • Neoplasm Metastasis
  • Organometallic Compounds / pharmacokinetics
  • Organometallic Compounds / therapeutic use*
  • Peptides / pharmacokinetics
  • Peptides / therapeutic use*
  • Positron-Emission Tomography
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / radiotherapy*
  • Radiopharmaceuticals / therapeutic use*
  • Tomography, X-Ray Computed

Substances

  • 177Lu-DKFZ-617
  • Antigens, Surface
  • Organometallic Compounds
  • Peptides
  • Radiopharmaceuticals
  • FOLH1 protein, human
  • Glutamate Carboxypeptidase II